Frequent inactivation of PTEN by promoter hypermethylation in microsatellite instability-high sporadic colorectal cancers - PubMed (original) (raw)
Frequent inactivation of PTEN by promoter hypermethylation in microsatellite instability-high sporadic colorectal cancers
Ajay Goel et al. Cancer Res. 2004.
Abstract
Loss of PTEN tumor suppressor function is observed in tumors of breast, prostate, thyroid, and endometrial origin. Allelic losses in the proximity of the PTEN locus (10q23) also occur in sporadic colorectal cancers (CRCs), but biallelic inactivation of this site has not been frequently demonstrated. We hypothesized that alternative mechanisms of PTEN allelic inactivation, such as promoter hypermethylation, might be operative in CRC and that PTEN inactivation may be related to recognized forms of genomic instability. We characterized a cohort of 273 sporadic CRCs by determining their microsatellite instability (MSI) status. Of these, 146 cancers were examined for PTEN promoter methylation by methylation-specific PCR. Mutations at the poly(A)6 repeat sequences in PTEN exons 7 and 8 and deletions at the 10q23 locus were also identified using microsatellite analysis. The presence of PTEN protein was determined by immunostaining, and the results were correlated with the promoter methylation status. We observed that PTEN promoter hypermethylation was a frequent occurrence in MSI-high (MSI-H) tumors (19.1% of MSI-H versus 2.2% of MSI-low/microsatellite stable tumors; P = 0.002). A PTEN mutation or a deletion event was present in 60% of the tumors with promoter region hypermethylation. Hypermethylation of the PTEN promoter correlated significantly with either decreased or complete loss of PTEN protein expression (P = 0.004). This is the first demonstration of PTEN inactivation as a result of promoter hypermethylation in MSI-H sporadic CRCs. These data suggest that this silencing mechanism plays a major role in PTEN inactivation and, in colon cancer, may be more important than either allelic losses or inactivating mutations. The significant correlation of PTEN hypermethylation with MSI-H tumors further suggests that PTEN is an additional important "target" of methylation along with the hMLH1 gene in the evolution of MSI-H CRCs and also confers the "second hit" in the biallelic inactivation mechanism for some proportion of tumors.
Similar articles
- PTEN mutational spectra, expression levels, and subcellular localization in microsatellite stable and unstable colorectal cancers.
Zhou XP, Loukola A, Salovaara R, Nystrom-Lahti M, Peltomäki P, de la Chapelle A, Aaltonen LA, Eng C. Zhou XP, et al. Am J Pathol. 2002 Aug;161(2):439-47. doi: 10.1016/S0002-9440(10)64200-9. Am J Pathol. 2002. PMID: 12163369 Free PMC article. - Distinction of hereditary nonpolyposis colorectal cancer and sporadic microsatellite-unstable colorectal cancer through quantification of MLH1 methylation by real-time PCR.
Bettstetter M, Dechant S, Ruemmele P, Grabowski M, Keller G, Holinski-Feder E, Hartmann A, Hofstaedter F, Dietmaier W. Bettstetter M, et al. Clin Cancer Res. 2007 Jun 1;13(11):3221-8. doi: 10.1158/1078-0432.CCR-06-3064. Clin Cancer Res. 2007. PMID: 17545526 - PTEN mutations are common in sporadic microsatellite stable colorectal cancer.
Nassif NT, Lobo GP, Wu X, Henderson CJ, Morrison CD, Eng C, Jalaludin B, Segelov E. Nassif NT, et al. Oncogene. 2004 Jan 15;23(2):617-28. doi: 10.1038/sj.onc.1207059. Oncogene. 2004. PMID: 14724591 - Promoter methylation in the genesis of gastrointestinal cancer.
Boland CR, Shin SK, Goel A. Boland CR, et al. Yonsei Med J. 2009 Jun 30;50(3):309-21. doi: 10.3349/ymj.2009.50.3.309. Epub 2009 Jun 23. Yonsei Med J. 2009. PMID: 19568590 Free PMC article. Review. - Genomic instability and colon cancer.
Grady WM. Grady WM. Cancer Metastasis Rev. 2004 Jan-Jun;23(1-2):11-27. doi: 10.1023/a:1025861527711. Cancer Metastasis Rev. 2004. PMID: 15000146 Review.
Cited by
- Obesity-Associated Colorectal Cancer.
Gonzalez-Gutierrez L, Motiño O, Barriuso D, de la Puente-Aldea J, Alvarez-Frutos L, Kroemer G, Palacios-Ramirez R, Senovilla L. Gonzalez-Gutierrez L, et al. Int J Mol Sci. 2024 Aug 14;25(16):8836. doi: 10.3390/ijms25168836. Int J Mol Sci. 2024. PMID: 39201522 Free PMC article. Review. - A Novel CRISPR/Cas9-mediated Mouse Model of Colon Carcinogenesis.
Kashima H, Fischer A, Veronese-Paniagua DA, Gazit VA, Ma C, Yan Y, Levin MS, Madison BB, Rubin DC. Kashima H, et al. Cell Mol Gastroenterol Hepatol. 2024 Aug 10;18(5):101390. doi: 10.1016/j.jcmgh.2024.101390. Online ahead of print. Cell Mol Gastroenterol Hepatol. 2024. PMID: 39128652 Free PMC article. - Cellular and molecular events in colorectal cancer: biological mechanisms, cell death pathways, drug resistance and signalling network interactions.
Yan L, Shi J, Zhu J. Yan L, et al. Discov Oncol. 2024 Jul 20;15(1):294. doi: 10.1007/s12672-024-01163-1. Discov Oncol. 2024. PMID: 39031216 Free PMC article. Review. - PI3K/Akt/mTOR Signaling Pathway as a Target for Colorectal Cancer Treatment.
Leiphrakpam PD, Are C. Leiphrakpam PD, et al. Int J Mol Sci. 2024 Mar 9;25(6):3178. doi: 10.3390/ijms25063178. Int J Mol Sci. 2024. PMID: 38542151 Free PMC article. Review. - Source, co-occurrence, and prognostic value of PTEN mutations or loss in colorectal cancer.
Serebriiskii IG, Pavlov VA, Andrianov GV, Litwin S, Basickes S, Newberg JY, Frampton GM, Meyer JE, Golemis EA. Serebriiskii IG, et al. NPJ Genom Med. 2023 Nov 24;8(1):40. doi: 10.1038/s41525-023-00384-7. NPJ Genom Med. 2023. PMID: 38001126 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
- R01 CA090231-03/CA/NCI NIH HHS/United States
- R01 CA090231/CA/NCI NIH HHS/United States
- R01-CA90231/CA/NCI NIH HHS/United States
- R01-CA 72851/CA/NCI NIH HHS/United States
- CA31946/CA/NCI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials